Source:http://linkedlifedata.com/resource/pubmed/id/10352313
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
1999-6-16
|
pubmed:abstractText |
The recognition of 16 mycobacterial Ags by a panel of T cell lines from leprosy patients and healthy exposed individuals from an endemic population was examined within the context of expressed HLA-DR molecules. Although overall no significant differences were found between the frequencies of Ag recognition in the different subject groups, when Ag-specific T cell responses were examined within the context of HLA-DR, a highly significant difference was found in the recognition of the 30/31-kDa Ag. HLA-DR3 appeared to be associated with high T cell responsiveness to the 30/31-kDa Ag in healthy contacts (p = 0.01), but, conversely, with low T cell responsiveness to this Ag in tuberculoid patients (p = 0.005). Within the group of HLA-DR3-positive individuals, differences in 30/31-kDa directed T cell responsiveness were highly significant not only between healthy individuals and tuberculoid patients (p < 0. 0001), but also between healthy individuals and lepromatous patients (p = 0.009), and consequently between healthy individuals compared with leprosy patients as a group (p < 0.0001). A dominant HLA-DR3-restricted epitope was recognized by healthy contacts in this population. It has been proposed that secreted Ags may dominate acquired immunity early in infection. The low T cell response to the secreted, immunodominant 30/31-kDa Ag in HLA-DR3-positive leprosy patients in this population may result in retarded macrophage activation and delayed bacillary clearance, which in turn may lead to enhanced Ag load followed by T cell-mediated immunopathology.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0022-1767
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
162
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
6912-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10352313-Antigens, Bacterial,
pubmed-meshheading:10352313-Epitope Mapping,
pubmed-meshheading:10352313-Epitopes, T-Lymphocyte,
pubmed-meshheading:10352313-HLA-DR Antigens,
pubmed-meshheading:10352313-HLA-DR3 Antigen,
pubmed-meshheading:10352313-Humans,
pubmed-meshheading:10352313-Immunophenotyping,
pubmed-meshheading:10352313-Leprosy,
pubmed-meshheading:10352313-Lymphocyte Activation,
pubmed-meshheading:10352313-Molecular Weight,
pubmed-meshheading:10352313-Mycobacterium leprae,
pubmed-meshheading:10352313-T-Lymphocytes
|
pubmed:year |
1999
|
pubmed:articleTitle |
HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens.
|
pubmed:affiliation |
Immunohaematology and Bloodbank, Department of Dermatology, Leiden University Medical Center, The Netherlands. j.thole@pg.tno.nl
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|